Early Intervention Strategies for Dry AMD & Presbyopia

WATCH FOR CREDIT: https://axiomoph.com/cope-ve26-dry-am... Program Description: This course covers early intervention strategies for geographic atrophy and presbyopia, highlighting the importance of timely diagnosis, newer therapeutics that slow disease progression, and an overview of currently available pharmacological treatment options for presbyopia, including recently FDA-approved agents and guidance on patient selection. Faculty: • Steven Ferrucci, OD, FAAO • Joshua Davidson, OD, FAAO, FSLS • Selina McGee, OD, FAAO • Mary Beth Yackey, OD Learning Objectives: After completing this course, learners will be able to: • Summarize the prevalence of early-stage presbyopia and the incidence and risk factors for the development of intermediate dry AMD and GA and the impact on functional and anatomical outcomes (Knowledge) • Compare the mechanisms of action for current and emerging pharmaceutical treatments of early-stage presbyopia based on published clinical trial data and real-world reports, and identify ideal patient candidates for the treatment options (Knowledge, Competence, Performance) • Integrate multimodal diagnostic strategies, including OCT-A, for early diagnosis and classification of dry AMD/GA (Competence, Performance) • Assess safety and efficacy data for new and emerging intermediate dry AMD and GA treatments, including complement inhibition and multiwavelength photobiomodulation, understand the importance of earlier intervention, and initiate early collaborative management with retina specialists who are utilizing these therapies (Knowledge, Competence, performance) Credit: This enduring educational activity is eligible for 0.5 hours of COPE credit.